| Current Price | $228.31 | Mkt Cap | $140.2B |
|---|---|---|---|
| Open | $238.37 | P/E Ratio | 18.78 |
| Prev. Close | $228.31 | Div. (Yield) | $7.04 (2.9%) |
| Daily Range | $227.10 - $239.42 | Volume | 6,952,767 |
| 52-Wk Range | $210.28 - $276.69 | Avg. Daily Vol. | 2,357,278 |
A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology.
| Current Price | $228.31 | Mkt Cap | $140.2B |
|---|---|---|---|
| Open | $238.37 | P/E Ratio | 18.78 |
| Prev. Close | $228.31 | Div. (Yield) | $7.04 (2.9%) |
| Daily Range | $227.10 - $239.42 | Volume | 6,952,767 |
| 52-Wk Range | $210.28 - $276.69 | Avg. Daily Vol. | 2,357,278 |
The best Bull and Bear pitches based on recency and number of recommendations.
Terrific company and has a game changing migraine drug in early monetization stage. Trading near December lows now and is too darn cheap
Read the most recent pitches from players about AMGN.
Recs
cwardfs
(< 20)
Submitted: 3/5/2021 7:37:24 PM :
Start Price:
$225.56
NASDAQ:AMGN Score:
-13.38
The medical field will have a promising change for human kind.
Recs
Kona2018
(37.00)
Submitted: 2/21/2021 5:36:20 PM :
Start Price:
$230.41
NASDAQ:AMGN Score:
-14.33
Industry leader
Recs
TMFjbonefish
(69.06)
Submitted: 1/12/2021 7:20:54 PM :
Start Price:
$235.48
NASDAQ:AMGN Score:
-18.98
Stable of products can withstand generics while they keep paying a rising dividend.
Find the members with the highest scoring picks in AMGN.
TrackSoros (< 20) Score: +465.40
The Score Leader is the player with the highest score across all their picks in AMGN.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| Gardere | < 20 | 3/20/2008 |
|
NS | $31.37 | +627.83% | +248.11% | +379.73 | 0 Comment | |
|
golfdynamo | < 20 | 3/24/2008 |
|
NS | $31.68 | +620.58% | +241.52% | +379.06 | 0 Comment |
| bappy29 | < 20 | 3/24/2008 |
|
3W | $31.68 | +620.58% | +241.52% | +379.06 | 1 Comment | |
| gokulesh | < 20 | 3/24/2008 |
|
3Y | $31.68 | +620.58% | +241.52% | +379.06 | 0 Comment | |
| RyWoods | 52.54 | 3/24/2008 |
|
3Y | $31.68 | +620.58% | +241.52% | +379.06 | 0 Comment | |
| dhcrosse | 79.14 | 3/24/2008 |
|
1Y | $31.68 | +620.58% | +241.52% | +379.06 | 0 Comment | |
| KarenSmart | < 20 | 3/24/2008 |
|
NS | $31.68 | +620.58% | +241.52% | +379.06 | 0 Comment | |
| jchrismc | < 20 | 3/24/2008 |
|
1Y | $31.68 | +620.58% | +241.52% | +379.06 | 0 Comment | |
| GFunkmeister | < 20 | 3/26/2008 |
|
3W | $32.14 | +610.45% | +238.61% | +371.85 | 0 Comment | |
| kerrdog65 | 26.97 | 3/26/2008 |
|
1Y | $32.14 | +610.45% | +238.61% | +371.85 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
